Display options
Share it on

Cancer Manag Res. 2015 Sep 11;7:291-9. doi: 10.2147/CMAR.S34859. eCollection 2015.

Targeting autophagy in cancer management - strategies and developments.

Cancer management and research

Bulent Ozpolat, Doris M Benbrook

Affiliations

  1. Department of Experimental Therapeutics, The University of Texas - Houston, MD Anderson Cancer Center, Houston, TX, USA.
  2. Department of Obstetrics and Gynecology, University of Oklahoma HSC, Oklahoma City, OK, USA.

PMID: 26392787 PMCID: PMC4573074 DOI: 10.2147/CMAR.S34859

Abstract

Autophagy is a highly regulated catabolic process involving lysosomal degradation of intracellular components, damaged organelles, misfolded proteins, and toxic aggregates, reducing oxidative stress and protecting cells from damage. The process is also induced in response to various conditions, including nutrient deprivation, metabolic stress, hypoxia, anticancer therapeutics, and radiation therapy to adapt cellular conditions for survival. Autophagy can function as a tumor suppressor mechanism in normal cells and dysregulation of this process (ie, monoallelic Beclin-1 deletion) may lead to malignant transformation and carcinogenesis. In tumors, autophagy is thought to promote tumor growth and progression by helping cells to adapt and survive in metabolically-challenged and harsh tumor microenvironments (ie, hypoxia and acidity). Recent in vitro and in vivo studies in preclinical models suggested that modulation of autophagy can be used as a therapeutic modality to enhance the efficacy of conventional therapies, including chemo and radiation therapy. Currently, more than 30 clinical trials are investigating the effects of autophagy inhibition in combination with cytotoxic chemotherapies and targeted agents in various cancers. In this review, we will discuss the role, molecular mechanism, and regulation of autophagy, while targeting this process as a novel therapeutic modality, in various cancers.

Keywords: autophagy inhibition; chemotherapy; tumor microenvironment

References

  1. Int J Biochem Cell Biol. 2004 Dec;36(12):2491-502 - PubMed
  2. Autophagy. 2008 Jul;4(5):669-79 - PubMed
  3. Nat Rev Mol Cell Biol. 2014 Mar;15(3):153 - PubMed
  4. Cell Tissue Res. 2002 Sep;309(3):409-16 - PubMed
  5. Cancer Res. 2001 Jan 15;61(2):439-44 - PubMed
  6. Cancer Cell. 2003 Dec;4(6):422-4 - PubMed
  7. Hum Mol Genet. 2006 Oct 1;15(19):2962-71 - PubMed
  8. Cell Death Differ. 2004 Apr;11(4):448-57 - PubMed
  9. Mol Cell Biol. 2005 Feb;25(3):1025-40 - PubMed
  10. J Pathol. 2012 Dec;228(4):437-47 - PubMed
  11. Hematol Oncol Stem Cell Ther. 2013 Mar;6(1):20-5 - PubMed
  12. Genes Dev. 2007 Jul 1;21(13):1621-35 - PubMed
  13. Autophagy. 2014 Aug;10 (8):1369-79 - PubMed
  14. Mol Ther Nucleic Acids. 2013 Sep 10;2:e121 - PubMed
  15. Cell Death Differ. 2007 Mar;14 (3):548-58 - PubMed
  16. Autophagy. 2011 Nov;7(11):1371-8 - PubMed
  17. J Cell Sci. 2006 Feb 15;119(Pt 4):605-14 - PubMed
  18. Breast Cancer Res Treat. 2008 Dec;112(3):389-403 - PubMed
  19. Blood. 2007 Jul 1;110(1):313-22 - PubMed
  20. Cancer Res. 2008 Mar 1;68(5):1485-94 - PubMed
  21. Autophagy. 2014 Aug;10(8):1415-25 - PubMed
  22. Curr Biol. 2012 Jan 10;22(1):R29-34 - PubMed
  23. Autophagy. 2014 Aug;10(8):1403-14 - PubMed
  24. Radiat Oncol. 2013 Sep 08;8:209 - PubMed
  25. Ann Intern Med. 2006 Mar 7;144(5):337-43 - PubMed
  26. J Pathol. 2007 Jan;211(2):134-43 - PubMed
  27. Cell Death Differ. 2013 Jan;20(1):31-42 - PubMed
  28. Clin Cancer Res. 2012 Jan 15;18(2):370-9 - PubMed
  29. J Biol Chem. 2000 Jan 14;275(2):992-8 - PubMed
  30. J Biol Chem. 2008 Mar 14;283(11):6783-9 - PubMed
  31. Trends Biochem Sci. 2007 Jan;32(1):37-43 - PubMed
  32. Autophagy. 2007 Jan-Feb;3(1):72-4 - PubMed
  33. Curr Biol. 2007 Jan 9;17 (1):1-11 - PubMed
  34. Cancer Res. 2001 Apr 15;61(8):3443-9 - PubMed
  35. Am J Cancer Res. 2012;2(4):397-413 - PubMed
  36. Cancer Res. 1995 Mar 1;55(5):1002-5 - PubMed
  37. Cell. 2005 Sep 23;122(6):927-39 - PubMed
  38. J Clin Invest. 2003 Dec;112(12 ):1809-20 - PubMed
  39. Annu Rev Pharmacol Toxicol. 2012;52:381-400 - PubMed
  40. Autophagy. 2014 Aug;10(8):1380-90 - PubMed
  41. J Biol Chem. 2001 Sep 21;276(38):35243-6 - PubMed
  42. Nat Rev Cancer. 2005 Sep;5(9):726-34 - PubMed
  43. Curr Mol Med. 2009 May;9(4):417-24 - PubMed
  44. Genes Dev. 2011 Mar 1;25(5):460-70 - PubMed
  45. J Clin Invest. 2008 Dec;118(12):3917-29 - PubMed
  46. Nat Rev Cancer. 2005 Nov;5(11):886-97 - PubMed
  47. Oncogene. 2007 Jun 14;26(28):4071-83 - PubMed
  48. Genes Dev. 2013 Jul 1;27(13):1447-61 - PubMed
  49. Biochim Biophys Acta. 2003 Mar 17;1603(2):113-28 - PubMed
  50. FEBS Lett. 2010 Apr 2;584(7):1287-95 - PubMed
  51. Curr Biol. 2005 Aug 23;15(16):1513-7 - PubMed
  52. PLoS One. 2013;8(1):e55096 - PubMed
  53. J Biol Chem. 2003 May 9;278(19):16667-74 - PubMed
  54. Autophagy. 2012 Apr;8(4):445-544 - PubMed
  55. Annu Rev Cell Dev Biol. 2011;27:107-32 - PubMed
  56. Autophagy. 2010 Apr;6(3):322-9 - PubMed
  57. Neurobiol Dis. 2007 Feb;25(2):252-65 - PubMed
  58. Invest Ophthalmol Vis Sci. 2010 Nov;51(11):6030-7 - PubMed
  59. Nature. 1999 Dec 9;402(6762):672-6 - PubMed
  60. Proc Natl Acad Sci U S A. 2005 Oct 4;102(40):14132-8 - PubMed
  61. Cell Mol Life Sci. 2012 Apr;69(7):1125-36 - PubMed
  62. Cancer Res. 2005 Apr 15;65(8):3336-46 - PubMed
  63. Autophagy. 2007 Sep-Oct;3(5):480-3 - PubMed
  64. Nat Cell Biol. 2010 Sep;12(9):814-22 - PubMed
  65. J Biol Chem. 2012 Jun 1;287(23):19094-104 - PubMed
  66. Cell. 2008 Jan 11;132(1):27-42 - PubMed
  67. Cancer Res. 1993 Jul 15;53(14):3382-5 - PubMed
  68. Oncogene. 2012 Feb 23;31(8):939-53 - PubMed
  69. Autophagy. 2014 Aug;10 (8):1359-68 - PubMed
  70. Cell Death Differ. 2007 Mar;14(3):500-10 - PubMed
  71. Autophagy. 2014 Aug;10(8):1391-402 - PubMed
  72. J Clin Invest. 2007 Feb;117(2):326-36 - PubMed
  73. Drug Resist Updat. 2010 Jun;13(3):87-92 - PubMed

Publication Types